Medicine and Health Campaign

Advancing diabetes research

World-renowned scientists at the University of Minnesota are leading the way in developing advanced treatments and potential cures for type 1 and 2 diabetes, thanks to a community charitable supporters.

Type 1 diabetes is caused by the immune system’s destruction of insulin-producing cells, known as islets, in the pancreas. University researchers established a standardized treatment for human islet-cell transplantation, which is now in the final stages of review by the U.S. Food and Drug Administration to become a routine medical procedure for treating type 1 diabetes in certain patients.

Philanthropic support makes discovery possible

With the help of charitable gifts, U scientists and physicians are:

  • seeking ways to prevent islets from being killed by the body and protect replaced or regenerated islets and organs in patients with type 1 diabetes
  • establishing an unlimited source of islet cells for transplantation using pig islets and creating insulin-producing islet cells from adult stem cells
  • participating in TrialNet, a global network of researchers working on diabetes prevention and early treatment
  • developing more effective ways to prevent, better manage, and reverse type 2 diabetes
  • providing surgical solutions and developing new drugs to address the challenges of diabetes

Your support can change lives. Give today.

Read more

View additional stories on Diabetes

A bioartificial pancreas, combined with innovative monitoring, may offer new hope for those with type I diabetes. Read More »
The U’s Aaron Doering helps connect those most affected by climate change with an audience of millions. Read More »
Finding a cure for diabetes is a longtime passion for immunologist Brian Fife, Ph.D. It’s also deeply personal. Learn more about how Fife has observed the impact of this devastating disease firsthand. Read More »

Leaders in diabetes Research, Care


Discoveries in Diabetes

Discoveries in Diabetes

Contact us

Jean Gorell, CRFE
Senior Director of Development, Diabetes, Surgery and Special Initiatives